Salarius Pharmaceuticals, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Salarius Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Salarius Pharmaceuticals, Inc. for February 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 20 2020 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Buy | P | 0.95 | 2,000 | 1,900 | 7,000 | 5 K to 7 K (+40.00 %) |
Feb 18 2020 | FLKS | Salarius Pharmaceu ... | Jordan Scott | Chief Business Offi ... | Buy | P | 0.90 | 11,300 | 10,170 | 31,609 | 20.3 K to 31.6 K (+55.64 %) |
Feb 18 2020 | FLKS | Salarius Pharmaceu ... | Jordan Scott | Chief Business Offi ... | Buy | P | 0.90 | 11,300 | 10,170 | 31,609 | 20.3 K to 31.6 K (+55.64 %) |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Burleson Tess | Director | Option Exercise | P | 1.15 | 4,350 | 5,003 | 4,350 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | McVicar William K. | Director | Option Exercise | P | 1.15 | 8,700 | 10,005 | 8,700 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | HANISH ARNOLD C | Director | Option Exercise | P | 1.15 | 4,350 | 5,003 | 4,350 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | McCreedy Bruce J Jr. | Director | Option Exercise | P | 1.15 | 8,700 | 10,005 | 8,700 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Rosenblum Mark J | Exec VP Finance, CF ... | Buy | P | 0.86 | 5,000 | 4,295 | 5,000 | 0 to 5 K |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Option Exercise | P | 1.15 | 2,175 | 2,501 | 2,175 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Northrup Jonathan P | Director | Option Exercise | P | 1.15 | 8,700 | 10,005 | 8,700 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Option Exercise | P | 1.15 | 2,175 | 2,501 | 2,175 | |
Feb 13 2020 | FLKS | Salarius Pharmaceu ... | Northrup Jonathan P | Director | Option Exercise | P | 1.15 | 8,700 | 10,005 | 8,700 | |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | McVicar William K. | Director | Buy | P | 1.15 | 8,700 | 10,005 | 8,700 | 0 to 8.7 K |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | Northrup Jonathan P | Director | Buy | P | 1.15 | 8,700 | 10,005 | 352,713 | 344 K to 352.7 K (+2.53 %) |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | Burleson Tess | Director | Buy | P | 1.15 | 4,350 | 5,003 | 4,350 | 0 to 4.4 K |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | HANISH ARNOLD C | Director | Buy | P | 1.15 | 4,350 | 5,003 | 7,350 | 3 K to 7.4 K (+145.00 %) |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | McCreedy Bruce J Jr. | Director | Buy | P | 1.15 | 8,700 | 10,005 | 8,700 | 0 to 8.7 K |
Feb 12 2020 | FLKS | Salarius Pharmaceu ... | Arthur David J. | Chief Executive Off ... | Buy | P | 1.15 | 2,175 | 2,501 | 81,546 | 79.4 K to 81.5 K (+2.74 %) |